SRBT:OTC-Shanrong Biotechnology Corp (USD)

COMMON STOCK | Shell Companies |

Last Closing

USD 0.28

Change

0.00 (0.00)%

Market Cap

USD 0.31B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Shell Companies

Symbol Name Price(Change) Market Cap
DVTC Development Technologies Corp

N/A

USD 1.09B
PBAJ Petro Usa Inc

-5.00 (-100.00%)

USD 1.00B
UHGI Ultimate Holdings Group Inc.

N/A

USD 0.61B
SCGX Saxon Capital Group Inc

N/A

USD 0.57B
WFHG World Financial Holding Group

N/A

USD 0.47B
PUCKW Goal Acquisitions Corp

N/A

USD 0.32B
PUCKU Goal Acquisitions Corp Unit

N/A

USD 0.32B
ABVN ABV Consulting Inc

N/A

USD 0.18B
NFSCF Enphys Acquisition Corp.

N/A

USD 0.17B
NFTN NFiniTi inc.

N/A

USD 0.13B

ETFs Containing SRBT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Shell Companies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 191.67% 86% B+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 191.67% 86% B+ 96% N/A
Trailing 12 Months  
Capital Gain -24.32% 43% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.32% 42% F 34% F
Trailing 5 Years  
Capital Gain -0.71% 67% D+ 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.71% 67% D+ 50% F
Average Annual (5 Year Horizon)  
Capital Gain 300.79% 73% C 92% A
Dividend Return 300.79% 73% C 92% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 636.20% 38% F 12% F
Risk Adjusted Return 47.28% 87% B+ 83% B
Market Capitalization 0.31B 96% N/A 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.